Official Title
Expanded Access for ACE-011
Brief Summary
This is an expanded access program (EAP) for eligible participants designed to provideaccess to ACE-011.
No longer available
Individual Patients
Myelodysplastic Syndrome
Drug: ACE-011
ACE-011 will be administered subcutaneous injection
Other Name: Sotatercept
Eligibility Criteria
Inclusion Criteria:
- Exclusion Criteria:
-
Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
United States
Locations
Celgene
Summit, New Jersey, United States
Celgene
NCT Number
Keywords
Expanded Access
Compassionate Use
MeSH Terms
Myelodysplastic Syndromes